{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:05:39Z","timestamp":1740107139158,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00403-020-02150-6","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T18:03:07Z","timestamp":1603389787000},"page":"301-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital"],"prefix":"10.1007","volume":"314","author":[{"given":"Aikaterini","family":"Tsentemeidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6235-4718","authenticated-orcid":false,"given":"Elena","family":"Sotiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Vakirlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demeter","family":"Ioannides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"2150_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1365-2133.2010.09773.x","volume":"163","author":"S Esmann","year":"2010","unstructured":"Esmann S, Dufour DNN, Jemec GBEBEE (2010) Questionnaire-based diagnosis of hidradenitissuppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions. Br J Dermatol 163:102\u2013106. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09773.x","journal-title":"Br J Dermatol"},{"key":"2150_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2167-1079.1000181","volume":"05","author":"V Tzanetakou","year":"2015","unstructured":"Tzanetakou V (2015) Estimating quality of life in greek patients with hidradenitissuppurativa. Prim Heal Care Open Access 05:1\u20136. https:\/\/doi.org\/10.4172\/2167-1079.1000181","journal-title":"Prim Heal Care Open Access"},{"key":"2150_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","volume":"71","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Chen AJ, Kim GE, Kimball AB (2014) Hidradenitissuppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis. J Am AcadDermatol 71:1144\u20131150. https:\/\/doi.org\/10.1016\/j.jaad.2014.09.012","journal-title":"J Am AcadDermatol"},{"key":"2150_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40257-014-0105-5","volume":"16","author":"A Alavi","year":"2015","unstructured":"Alavi A, Anooshirvani N, Kim WB, Coutts P, Sibbald RG (2015) Quality-of-life impairment in patients with hidradenitissuppurativa: a canadian study. Am J ClinDermatol 16:61\u201365. https:\/\/doi.org\/10.1007\/s40257-014-0105-5","journal-title":"Am J ClinDermatol"},{"key":"2150_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-019-09640-4","author":"S Tugnoli","year":"2019","unstructured":"Tugnoli S, Agnoli C, Silvestri A et al (2019) Anger, emotional fragility, self-esteem, and psychiatric comorbidity in patients with hidradenitissuppurativa\/acne inversa. J ClinPsychol Med Settings. https:\/\/doi.org\/10.1007\/s10880-019-09640-4","journal-title":"J ClinPsychol Med Settings"},{"key":"2150_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/bjd.17396","volume":"181","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis CC (2019) The socioeconomic burden of hidradenitissuppurativa\/acne inversa. Br J Dermatol 181:7\u20138","journal-title":"Br J Dermatol"},{"key":"2150_CR7","doi-asserted-by":"publisher","first-page":"e0200683","DOI":"10.1371\/journal.pone.0200683","volume":"13","author":"M Calao","year":"2018","unstructured":"Calao M, Wilson JL, Spelman L et al (2018) HidradenitisSuppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study. PLoS ONE 13:e0200683. https:\/\/doi.org\/10.1371\/journal.pone.0200683","journal-title":"PLoS ONE"},{"key":"2150_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A et al (2019a) North American clinical management guidelines for hidradenitissuppurativa: A publication from the United States and Canadian HidradenitisSuppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am AcadDermatol 81:76\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.067","journal-title":"J Am AcadDermatol"},{"key":"2150_CR9","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/aje\/kwu078","volume":"179","author":"K McMillan","year":"2014","unstructured":"McMillan K (2014) Hidradenitissuppurativa: Number of diagnosed patients, demographic characteristics, and treatment patterns in the United States. Am J Epidemiol 179:1477\u20131483. https:\/\/doi.org\/10.1093\/aje\/kwu078","journal-title":"Am J Epidemiol"},{"key":"2150_CR10","doi-asserted-by":"publisher","unstructured":"(2017) Concomitant antibiotic use in patients with moderate-to-severe hidradenitis suppurativa who were treated with adalimumab or placebo in a phase 3 study (PIONEER II). J Am Acad Dermatol 76:AB81. https:\/\/doi.org\/10.1016\/j.jaad.2017.04.329","DOI":"10.1016\/j.jaad.2017.04.329"},{"key":"2150_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A et al (2019b) North American clinical management guidelines for hidradenitissuppurativa: A publication from the United States and Canadian HidradenitisSuppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am AcadDermatol 81:91\u2013101. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.068","journal-title":"J Am AcadDermatol"},{"key":"2150_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jdv.12127","volume":"28","author":"V Bettoli","year":"2014","unstructured":"Bettoli V, Zauli S, Borghi A et al (2014) Oral clindamycin and rifampicin in the treatment of hidradenitissuppurativa-acne inversa: A prospective study on 23 patients. J EurAcad Dermatology Venereol 28:125\u2013126","journal-title":"J EurAcad Dermatology Venereol"},{"key":"2150_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000228337","volume":"219","author":"HH van der Zee","year":"2009","unstructured":"van der Zee HH, Boer J, Prens EP, Jemec GBE (2009) The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitissuppurativa. Dermatology 219:143\u2013147. https:\/\/doi.org\/10.1159\/000228337","journal-title":"Dermatology"},{"key":"2150_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000332846","volume":"223","author":"HH van der Zee","year":"2011","unstructured":"van der Zee HH, Prens EP (2011) the anti-inflammatory drug colchicine lacks efficacy in hidradenitissuppurativa. Dermatology 223:169\u2013173. https:\/\/doi.org\/10.1159\/000332846","journal-title":"Dermatology"},{"key":"2150_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ijd.13428","volume":"56","author":"K Armyra","year":"2017","unstructured":"Armyra K, Kouris A, Markantoni V et al (2017) Hidradenitissuppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients. Int J Dermatol 56:346\u2013350. https:\/\/doi.org\/10.1111\/ijd.13428","journal-title":"Int J Dermatol"},{"key":"2150_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000329023","volume":"222","author":"S Yazdanyar","year":"2011","unstructured":"Yazdanyar S, Boer J, Ingvarsson G et al (2011) Dapsone therapy for hidradenitissuppurativa: A series of 24 patients. Dermatology 222:342\u2013346. https:\/\/doi.org\/10.1159\/000329023","journal-title":"Dermatology"},{"key":"2150_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/09546630600830588","volume":"17","author":"MR Kaur","year":"2006","unstructured":"Kaur MR, Lewis HM (2006) Hidradenitissuppurativa treated with dapsone: A case series of five patients. J Dermatolog Treat 17:211\u2013213. https:\/\/doi.org\/10.1080\/09546630600830588","journal-title":"J Dermatolog Treat"},{"key":"2150_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","volume":"62","author":"A Grant","year":"2010","unstructured":"Grant A, Gonzalez T, Montgomery MO et al (2010) Infliximab therapy for patients with moderate to severe hidradenitissuppurativa: A randomized, double-blind, placebo-controlled crossover trial. J Am AcadDermatol 62:205\u2013217. https:\/\/doi.org\/10.1016\/j.jaad.2009.06.050","journal-title":"J Am AcadDermatol"},{"key":"2150_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/bjd.12713","volume":"170","author":"B Moriarty","year":"2014","unstructured":"Moriarty B, Jiyad Z, Creamer D (2014) Four-weekly infliximab in the treatment of severe hidradenitissuppurativa. Br J Dermatol 170:986\u2013987","journal-title":"Br J Dermatol"},{"key":"2150_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/jdv.15647","volume":"33","author":"Rowland Payne PCME","year":"2019","unstructured":"Rowland Payne PCME (2019) Hidradenitissuppurativa treatment \u2013 medical or surgical? J EurAcad Dermatology Venereol 33:981\u2013982","journal-title":"J EurAcad Dermatology Venereol"},{"key":"2150_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000462979","volume":"3","author":"N Scuderi","year":"2017","unstructured":"Scuderi N, Monfrecola A, Dessy LA et al (2017) Medical and surgical treatment of hidradenitissuppurativa: a review. Ski Appendage Disord 3:95\u2013110","journal-title":"Ski Appendage Disord"},{"key":"2150_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jdv.15233","volume":"33","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis CC, Bechara FG, Dickinson-Blok JL et al (2019) Hidradenitissuppurativa\/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group. J EurAcadDermatolVenereol 33:19\u201331. https:\/\/doi.org\/10.1111\/jdv.15233","journal-title":"J EurAcadDermatolVenereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02150-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02150-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02150-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T12:04:46Z","timestamp":1647086686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02150-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02150-6","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"type":"print","value":"0340-3696"},{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have any conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}